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Rerkasem K., Rothwell P.M. Eur J Vasc Endovasc Surg 2009;xx:xx-xx.
Objectives: To determine whether there is any evidence of a systematic
reduction in the operative risk of carotid endarterectomy (CEA) for symp-
tomatic stenosis in recent years.
Methods: We performed a systematic review of all studies published
between 2000 and 2008 inclusive that reported the risks of stroke and death
for symptomatic carotid stenosis. We compared the reported risks with our
previous review of studies published prior to 2001 and between studies that
were reported by surgeons alone and studies that included neurologists or
stroke physicians as assessors/authors, with particular reference to the
proportion of operative strokes to operative deaths.
Results: Of 494 studies, only 53 reported operative risks for patients
with symptomatic stenosis separately. In keeping with the findings of our
previous review, the pooled operative risk of stroke and death reported in
studies published by surgeons alone (3.9%, 95% confidence interval (CI):
3.4–4.3) was significantly lower (p  0.001) than that reported in studies
that involved neurologists (5.6%, 95% CI: 5.1–6.2). The pooled ratio of
operative stroke:operative death was 4.0 (range: 3.6–4.5) in studies involv-
ing neurologists or stroke physicians and 2.7 (range: 2.1–3.9) in studies
involving only surgeons (p  0.002). We found no evidence of a reduction
in published risks of death or stroke and death due to CEA for symptomatic
carotid stenosis between 1985 and 2008. Indeed, the 1.4% (range: 1.2–
1.6%) pooled operative mortality in studies published during 2001–2008
was significantly higher than that reported in ECST and NASCET (1.0%,
95% CI: 0.9–1.1%). However, the average age of patients having CEA has
continued to increase during this period.
Conclusions: There is no evidence of a systematic reduction over the
last decade in the published risks due to CEA for symptomatic stenosis. The
lower proportion of non-fatal operative strokes in surgeon-only studies
suggests that some minor operative strokes have been missed.
Early Carotid Endarterectomy after Intravenous Thrombolysis for
Acute Ischaemic Stroke
Bartoli M.A., Squarcioni C., Nicoli F., Magnan P.-E., Malikov S., Berger L.,
Lerussi G.B., Branchereau A. Eur J Vasc Endovasc Surg 2009;xx:xx-xx.
After intravenous thrombolysis (IVT) for acute ischaemic stroke
(AIS), a severe cervical internal carotid artery (ICA) stenosis may remain
and increase the risk of recurrent stroke. Carotid endarterectomy (CEA)
has been shown to be effective in reducing the risk of stroke. However, it
is not well known whether CEA can be performed safely after thrombol-
ysis, and, if so, when. We report a prospective study of CEA for residual
high-grade cervical ICA stenosis performed within 15 days after IVT
for AIS.
Methods: All the patients had a brain magnetic resonance imaging
(MRI) within 3 h of the stroke onset. One day after IVT in neurovascu-
lar unit, computed tomography (CT) angiography was performed to
assess the brain and the patency of cervical arteries. CEA was per-
formed on neurologically stable patients after full cerebral artery re-
canalisation. Blood pressure was controlled with particular caution be-
fore and after CEA.
Results: Between January 2005 and January 2008, we operated con-
secutively on 12 patients. Their median National Institutes of Health Stroke
Scale (NIHSS) score was 12 (range: 5–21). Combined intracranial (ICA)–
middle cerebral artery (MCA) occlusion was present in 58.3% of the patients.
The median time between onset of symptoms until CEA was 8 days (range:
1–16 days). Stroke and death rate at 30 days was 8.3% (one nonfatal
haemorrhagic stroke). At 90 days, nine patients had a Rankin score of 0–1,
one had a score of 2 and two had a score of 3.
Conclusion: In patients with residual cervical ICA stenosis after IVT,
we achieved full patency of the occluded artery and good functional prog-
nosis at 3 months in all cases. We advocate for an extremely close monitoring
of the blood pressure in the pre-, peri- and post-operative course and a close
collaboration between neurologist and surgeon to determine the best timing
for CEA.
1360Effect of Postoperative Restrictive Fluid Therapy in the Recovery of
Patients with Abdominal Vascular Surgery
González-Fajardo J.A., Mengibar L., Brizuela J.A., Castrodeza J., Vaquero-
Puerta C. Eur J Vasc Endovasc Surg 2009;xx:xx-xx.
Objective: To compare the outcome of the postoperative administra-
tion of a restricted or standard intravenous fluid regimen in patients who
underwent elective abdominal vascular surgery. The primary end point was
postoperative hospital stay.
Design: Prospective observer-blinded, randomised controlled trial.
Material and methods: Patients were considered eligible if they under-
went transperitoneal aorto-iliac approachwith infrarenal graft repair.During the
operation and intensive care unit stay, fluids were prescribed by the anaesthetists
who were unaware of the details of the study. In the vascular surgical ward,
patients in the standard group (SG) received 2500 ml of fluids per day, whereas
patients in the restricted group (RG) received 1500 ml of fluids per day. All the
patients were evaluated on an intention-to-treat basis.
Results: Forty patients were randomised to the RG (n  20) or SG
(n  20). No significant differences were observed in the recovery of gas-
trointestinal function. However, the postoperative hospital stay was shorter
in the RG (8 days) than in the SG (12 days) (p  0.003).
Conclusions: The use of a restrictive postoperative fluid protocol
significantly reduces the duration of hospital stay in patients who have
undergone major elective abdominal vascular surgery.
Concurrent Colorectal Malignancy and Abdominal Aortic Aneurysm:
A Multicentre Experience and Review of the Literature
Shalhoub J., Naughton P., Lau N., Tsang J.S., Kelly C.J., Leahy A.L.,
Cheshire N.J.W., Darzi A.W., Ziprin P. Eur J Vasc Endovasc Surg 2009;xx:
xx-xx.
Objectives: There is lack of consensus regarding concurrent vs. staged
approaches, and the prioritisation of staged procedures in cases presenting
with colorectal carcinoma (CRC) and abdominal aortic aneurysm (AAA)
synchronously. We aim to present our experience, review the literature on
this therapeutic dilemma and examine the role of endovascular aortic repair
(EVAR).
Design, materials and methods: An observational study of the expe-
rience of two centres and a systematic review of the published literature.
Results: Twenty-four patients were identified from the prospective data-
bases of two tertiary referral centres between 2001 and 2006. Intervention for
both malignancy and aneurysm was performed in 13 patients. In 10 patients,
cancer resection was performed initially and was followed by open aneurysm
repair (n 3) or EVAR (n 7). Two patients (AAA diameters: 7.0 and
8.0 cm) underwent EVAR prior to colonic resection. One patient was selected
for synchronous surgery. There were no interval AAA ruptures, graft infection
or postoperativemortalities. Literature review identified 269 such cases; of these
101 were treated by combined surgery. In staged surgery, there were nine
interval aneurysmal ruptures and one aortic graft infection.
Conclusions: In our experience, staged management can be under-
taken, without interval aneurysmal rupture. EVAR has an evolving role in
preventing delay in CRC management, in high-risk patients, and during
combined intervention.
PTFE Bypass or Thrupass for Superficial Femoral Artery Occlusion? A
Randomised Controlled Trial
Lepäntalo M., Laurila K., Roth W.-D., Rossi P., Lavonen J., Mäkinen K.,
Manninen H., Romsi P., Perälä J., Bergqvist D., Scandinavian Thrupass
Study Group Eur J Vasc Endovasc Surg 2009;xx:xx-xx.
Early results of a thrupass endograft in the treatment of femoral lesions
are promising. Less morbidity and better cost-effectiveness are suggested to
be achieved in the treatment of chronic lower limb ischaemia with endovas-
cular treatment compared to surgical treatment.
Patients and methods: This randomised multicentre trial aimed to
enroll a group of 60  60 patients for the treatment of 5–25-cm occlusions
of superficial femoral artery (SFA) to be followed up for 3 years. Patients
were treated either with endoluminal PTFE thrupass (WL Gore & Ass) or
with surgical polytetrafluoroethylene (PTFE) bypass to proximal popliteal
artery. Primary patency at 3 years was scheduled to be the primary end-point
and secondary patency, functional success, costs and quality of life the
secondary end-points.
